Low molecular weight dendritic compounds as pharmaceutical agents
This invention is for low molecular weight dendritic polymers (dendroids) of Formula I are useful as agents in the treatment of cancer, Alzheimers disease, thrombosis, inflammatory diseases, and bacterial resistance.
-
(2008/06/13)
More Articles about upstream products of 203583-54-4